procarbazine has been researched along with Hematologic Neoplasms in 7 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acquired ichthyosis is a rare condition that can reveal an unsuspected haematological malignancy, thus allowing early diagnosis and management." | 1.38 | [Acquired ichthyosis and haematological malignancies: five cases]. ( Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ, 2012) |
| "Procarbazine (PCB) was developed in the 1960s and was rapidly recognised as an active agent in lymphoid malignancies." | 1.32 | Procarbazine in haematology: an old drug with a new life? ( Armand, JP; Massoud, M; Ribrag, V, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berrady, R | 1 |
| Baybay, H | 1 |
| Khammar, Z | 1 |
| Lahlou, M | 1 |
| Lamchachti, L | 1 |
| Gallouj, S | 1 |
| El Hatimi, A | 1 |
| Mernissi, FZ | 1 |
| Bono, W | 1 |
| Rancea, M | 1 |
| Skoetz, N | 1 |
| Monsef, I | 1 |
| Hübel, K | 1 |
| Engert, A | 2 |
| Bauer, K | 1 |
| Ogawa, M | 1 |
| Massoud, M | 1 |
| Armand, JP | 1 |
| Ribrag, V | 1 |
| Kober, T | 1 |
| Hülsewede, H | 1 |
| Bohlius, J | 1 |
| Niitsu, N | 1 |
| Kato, M | 1 |
| Shikoshi, K | 1 |
| Umeda, M | 1 |
| Howell, SJ | 1 |
| Radford, JA | 1 |
| Adams, JE | 1 |
| Shalet, SM | 1 |
3 reviews available for procarbazine and Hematologic Neoplasms
| Article | Year |
|---|---|
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophospham | 2012 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine | 2003 |
Fourth biannual report of the Cochrane Haematological Malignancies Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2006 |
4 other studies available for procarbazine and Hematologic Neoplasms
| Article | Year |
|---|---|
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Ant | 2012 |
Procarbazine in haematology: an old drug with a new life?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Drug Resis | 2004 |
[Doxorubicin-induced myocardial damage in elderly patients with hematologic malignancies].
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols | 1997 |
The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition.
Topics: Adult; Antineoplastic Agents; Body Composition; Bone Density; Bone Diseases, Metabolic; Case-Control | 2000 |